| Product Code: ETC12463534 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Taiwan Imatinib Drug Market Overview | 
| 3.1 Taiwan Country Macro Economic Indicators | 
| 3.2 Taiwan Imatinib Drug Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Taiwan Imatinib Drug Market - Industry Life Cycle | 
| 3.4 Taiwan Imatinib Drug Market - Porter's Five Forces | 
| 3.5 Taiwan Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F | 
| 3.6 Taiwan Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.7 Taiwan Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F | 
| 3.8 Taiwan Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F | 
| 3.9 Taiwan Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F | 
| 4 Taiwan Imatinib Drug Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Taiwan | 
| 4.2.2 Growing awareness about targeted cancer therapies among healthcare professionals and patients | 
| 4.2.3 Favorable government regulations supporting access to innovative cancer treatments | 
| 4.3 Market Restraints | 
| 4.3.1 High cost of imatinib therapy leading to affordability issues for some patients | 
| 4.3.2 Stringent regulatory requirements for drug approval and market entry | 
| 4.3.3 Competition from generic imatinib drugs impacting market share of branded products | 
| 5 Taiwan Imatinib Drug Market Trends | 
| 6 Taiwan Imatinib Drug Market, By Types | 
| 6.1 Taiwan Imatinib Drug Market, By Drug Form | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Taiwan Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F | 
| 6.1.3 Taiwan Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F | 
| 6.1.4 Taiwan Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F | 
| 6.1.5 Taiwan Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F | 
| 6.1.6 Taiwan Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F | 
| 6.1.7 Taiwan Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F | 
| 6.2 Taiwan Imatinib Drug Market, By Application | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Taiwan Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F | 
| 6.2.3 Taiwan Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F | 
| 6.2.4 Taiwan Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F | 
| 6.2.5 Taiwan Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F | 
| 6.2.6 Taiwan Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F | 
| 6.3 Taiwan Imatinib Drug Market, By End User | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Taiwan Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F | 
| 6.3.3 Taiwan Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F | 
| 6.3.4 Taiwan Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F | 
| 6.3.5 Taiwan Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F | 
| 6.3.6 Taiwan Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F | 
| 6.4 Taiwan Imatinib Drug Market, By Sales Channel | 
| 6.4.1 Overview and Analysis | 
| 6.4.2 Taiwan Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F | 
| 6.4.3 Taiwan Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F | 
| 6.4.4 Taiwan Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F | 
| 6.4.5 Taiwan Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F | 
| 6.4.6 Taiwan Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F | 
| 6.5 Taiwan Imatinib Drug Market, By Mode of Administration | 
| 6.5.1 Overview and Analysis | 
| 6.5.2 Taiwan Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F | 
| 6.5.3 Taiwan Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F | 
| 6.5.4 Taiwan Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F | 
| 6.5.5 Taiwan Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F | 
| 6.5.6 Taiwan Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F | 
| 7 Taiwan Imatinib Drug Market Import-Export Trade Statistics | 
| 7.1 Taiwan Imatinib Drug Market Export to Major Countries | 
| 7.2 Taiwan Imatinib Drug Market Imports from Major Countries | 
| 8 Taiwan Imatinib Drug Market Key Performance Indicators | 
| 8.1 Patient adherence rate to imatinib therapy | 
| 8.2 Number of healthcare providers trained in prescribing and monitoring imatinib treatment | 
| 8.3 Rate of new CML diagnoses in Taiwan | 
| 9 Taiwan Imatinib Drug Market - Opportunity Assessment | 
| 9.1 Taiwan Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F | 
| 9.2 Taiwan Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.3 Taiwan Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F | 
| 9.4 Taiwan Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F | 
| 9.5 Taiwan Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F | 
| 10 Taiwan Imatinib Drug Market - Competitive Landscape | 
| 10.1 Taiwan Imatinib Drug Market Revenue Share, By Companies, 2024 | 
| 10.2 Taiwan Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |